StockNews.com assumed coverage on shares of Cancer Genetics (NASDAQ:CGIX – Get Rating) in a research report report published on Saturday morning. The brokerage issued a sell rating on the stock. Cancer Genetics Stock Down 15.8 % Cancer Genetics stock opened at $0.19 on Friday. Cancer Genetics has a 52 week low of $2.11 and a […]